Previous Close | 83.80 |
Open | 84.80 |
Bid | 82.42 x 300 |
Ask | 82.51 x 300 |
Day's Range | 82.32 - 84.80 |
52 Week Range | 76.02 - 99.56 |
Volume | |
Avg. Volume | 1,571,467 |
Market Cap | 15.654B |
Beta (5Y Monthly) | 0.32 |
PE Ratio (TTM) | 77.77 |
EPS (TTM) | 1.06 |
Earnings Date | Jul 29, 2024 - Aug 02, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 110.10 |
Last week, you might have seen that BioMarin Pharmaceutical Inc. ( NASDAQ:BMRN ) released its first-quarter result to...
Insightful Analysis of Biomarin Pharmaceutical Inc's Strengths, Weaknesses, Opportunities, and Threats
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2024 Earnings Call Transcript April 24, 2024 BioMarin Pharmaceutical Inc. beats earnings expectations. Reported EPS is $0.71, expectations were $0.6. BioMarin Pharmaceutical Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. My name […]